Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Tom R. Jones who wrote (2201)	11/22/1998 5:26:00 PM
From: Tom R. Jones	Read Replies (1) \| Respond to of 2395

Here is some research from Edgar: As of September 30, BICO had 398 million shares outstanding. The plan is to authorize 900 million by the end of the year. I also found this: <<During the three months ended September 30, 1998, the Company issued 4% Subordinate Convertible Debentures totaling $3,125,000 pursuant to sections 4 (2) and or Regulation D. Such debentures are convertible to the Company's restricted common stock at a price of approximately $.059 per share as of the date of this filing. The debentures were not saleable or convertible for a minimum of 90 days from issuance. (See "Management's Discussion and Analysis").>> Regards to all!